Health Care: Drugs

AVANIR Pharmaceuticals (AVNR: NASDAQ)

$5.28 -0.04 | -0.75%
07/22/14 - 04:00 PM ET
Company Income Statement
Sep 2013 Sep 2012 Sep 2011 Sep 2010
Sales 75.37M 41.28M 10.50M 2.90M
Cost of Sales 2.73M 1.21M 8.14K 197.64K
Gross Operating Profit 72.64M 40.07M 10.49M 2.70M
Selling, General, and Administrative Expenses 93.14M 74.49M 55.43M 16.47M
Research & Development 49.51M 23.07M 15.25M 13.32M
Operating Income before D & A (EBITDA) -70.00M -57.49M -60.19M -27.10M
Depreciation & Amortization 1.42M 913.06K 437.84K 205.00K
Interest Income 51.91K 42.82K 38.78K 15.02K
Other Income - Net -31.00 4.08K -37.73K 390.76K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -71.37M -58.36M -60.63M -26.90M
Interest Expense 4.10M 1.39M 0.00 0.00
Pre-Tax Income -75.47M -59.74M -60.63M -26.90M
Income Taxes 3.20K 3.20K 3.20K 3.20K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -75.48M -59.74M -60.63M -26.69M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -75.48M -59.74M -60.63M -26.69M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -75.48M -59.74M -60.63M -26.69M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-75.48M -59.74M -60.63M -26.69M
Preferred Dividends
Net Income Available To Common -75.48M -59.74M -60.63M -26.69M
Basic EPS from Continuing Ops. -0.53 -0.45 -0.51 -0.30
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.53 -0.45 -0.51 -0.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.53 -0.45 -0.51 -0.30
Basic Normalized Net Income/Share -0.53 -0.45 -0.51 -0.30
EPS fr Continuing Ops. -0.53 -0.45 -0.51 -0.30
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.53 -0.45 -0.51 -0.30
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.53 -0.45 -0.51 -0.30
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.53 -0.45 -0.51 -0.30
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with AVNR

Latest AVNR Headlines from TheStreet

More Financial News for AVNR

Press Releases for AVNR

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter